Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in ADCT — ADC Therapeutics SA

CIK 1692234 Seattle, WA
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$306,664
-$649,243 QoQ
Shares Held
286,604
+12.4% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 113 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. ADCT ranks #34 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 893,500 $64,206,902
2 NBIX
Neurocrine Biosciences Inc
 329,065 $55,460,607
3 VTRS
Viatris Inc
 3,423,675 $54,367,956
4 UTHR
UNITED THERAPEUTICS Corp
 61,355 $33,243,974
5 ELAN
Elanco Animal Health Inc
 1,112,894 $27,388,318
6 LNTH
Lantheus Holdings, Inc.
 147,146 $16,324,370
7 TEVA
Teva Pharmaceutical Industries Ltd
 427,444 $14,481,798
8 ALKS
Alkermes plc.
 222,624 $11,665,496

All Filings in ADCT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $306,664 286,604
2026-03-31 $955,907 254,909
2025-12-31 $86,597 24,532
2025-09-30 $130,008 32,502
2025-06-30 $66,466 24,801
2025-03-31 $55,960 39,688
2024-12-31 $33,420 16,794
2024-09-30 $23,769 7,546
2022-12-31 $68,352 17,800